125 related articles for article (PubMed ID: 32981606)
21. ALK positive malignant peritoneal mesothelioma mimicking inflammatory myofibroblastic tumour: a diagnostic pitfall.
Louw A; Wallace C; Chai SM; Amanuel B; Wong DD
Pathology; 2020 Oct; 52(6):719-722. PubMed ID: 32814620
[No Abstract] [Full Text] [Related]
22. Concurrent Presence of ALK Rearrangement and MET Mutation in Lung Adenocarcinoma.
Qiu T; Zhang F; Li W; Guo L; Ying J
J Thorac Oncol; 2019 Feb; 14(2):e42-e44. PubMed ID: 30683300
[No Abstract] [Full Text] [Related]
23. ALK detection in lung cancer: identification of atypical and cryptic ALK rearrangements using an optimal algorithm.
Liu Y; Wu S; Shi X; Liang Z; Zeng X
J Cancer Res Clin Oncol; 2020 May; 146(5):1307-1320. PubMed ID: 32128622
[TBL] [Abstract][Full Text] [Related]
24. Anaplastic lymphoma kinase expression in small-cell lung cancer.
Kondoh C; Horio Y; Hayashi Y; Ebi H; Hida T; Hasegawa Y; Yatabe Y
Histopathology; 2019 Jul; 75(1):20-28. PubMed ID: 30790327
[TBL] [Abstract][Full Text] [Related]
25. FISH Analysis of Crizotinib Target Genes ROS1/ALK/MET in Malignant Mesothelioma.
Salvi S; Varesano S; Boccardo S; Ravetti JL; Canessa PA; Pistillo MP; Ferro P; Fedeli F; Roncella S
J Thorac Oncol; 2017 Aug; 12(8):e116-e118. PubMed ID: 28748818
[No Abstract] [Full Text] [Related]
26. Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.
Chang JC; Zhang L; Drilon AE; Chi P; Alaggio R; Borsu L; Benayed R; Travis WD; Ladanyi M; Antonescu CR
J Thorac Oncol; 2019 May; 14(5):825-834. PubMed ID: 30550870
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the effectiveness of RNA in-situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement.
Nakajima N; Yoshizawa A; Kondo K; Rokutan-Kurata M; Hirata M; Furuhata A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Fujimoto M; Date H; Haga H
Histopathology; 2017 Jul; 71(1):143-149. PubMed ID: 28231386
[TBL] [Abstract][Full Text] [Related]
28. Novel method for rapid fluorescence in-situ hybridization of ALK rearrangement using non-contact alternating current electric field mixing.
Fujishima S; Imai K; Nakamura R; Nanjo H; Saito Y; Saito H; Terata K; Sato Y; Motoyama S; Akagami Y; Minamiya Y
Sci Rep; 2017 Nov; 7(1):15116. PubMed ID: 29118432
[TBL] [Abstract][Full Text] [Related]
29. Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study.
Liang H; Song X; Zhang Y; Zhang S; Li F; Fang J; Li J; Liang L; Nie L; Ma K; Zhang L; Wang X; Xu J; Wei Y; Wang J; Song Q; Tian G; Mu Y; Gu Y; Yang L; Sun P; Zhong W; Zhao J; Xu Y; Chen M; Wang M
Thorac Cancer; 2019 Jul; 10(7):1521-1532. PubMed ID: 31144459
[TBL] [Abstract][Full Text] [Related]
30. French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.
Lantuejoul S; Rouquette I; Blons H; Le Stang N; Ilie M; Begueret H; Grégoire V; Hofman P; Gros A; Garcia S; Monhoven N; Devouassoux-Shisheboran M; Mansuet-Lupo A; Thivolet F; Antoine M; Vignaud JM; Penault-Llorca F; Galateau-Sallé F; McLeer-Florin A
Eur Respir J; 2015 Jul; 46(1):207-18. PubMed ID: 25929957
[TBL] [Abstract][Full Text] [Related]
31. Molecular Testing for EGFR Mutations and ALK Rearrangements in the Cytological Specimens From the Patients With Non-Small Cell Lung Cancer.
Wang X; Chen S; Emerson RE; Wu HH; Cramer HM; Curless K; Chang HY; Zhang S; Randolph ML; Cheng L
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):119-124. PubMed ID: 30688675
[TBL] [Abstract][Full Text] [Related]
32. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
[TBL] [Abstract][Full Text] [Related]
33. [Pulmonary carcinosarcoma with ALK gene rearrangement: report of a case].
Lin ZH; Qiu XB; Fu JT; Gan DH
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):951-953. PubMed ID: 34344086
[TBL] [Abstract][Full Text] [Related]
34. Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.
Clavé S; Rodon N; Pijuan L; Díaz O; Lorenzo M; Rocha P; Taus Á; Blanco R; Bosch-Barrera J; Reguart N; de la Torre N; Oliveras G; Espinet B; Bellosillo B; Puig X; Arriola E; Salido M
Clin Lung Cancer; 2019 Jul; 20(4):e421-e429. PubMed ID: 30898567
[TBL] [Abstract][Full Text] [Related]
35. [Epidemiology and diagnosis of mutations in the ALK gene in patients with non-small cell lung cancer in the Moscow region].
Byakhova MM; Zavalishina LE; AndreevA YY; Tyulyandin SA; Tsimafeyeu IV; Imyanitov EN; Savelov NA; Demidova IA; Kekeyeva TV; Mueva NM; Frank GA
Arkh Patol; 2020; 82(3):18-23. PubMed ID: 32593262
[TBL] [Abstract][Full Text] [Related]
36. Development of a Novel One-Step Automated Rapid in situ Hybridization for Anaplastic Lymphoma Kinase Rearrangement Using Non-Contact Alternating-Current Electric-Field Mixing.
Imai K; Takashima S; Fujishima S; Matsuo T; Watanabe SN; Nanjo H; Akagami Y; Nakamura R; Terata K; Wakita A; Sato Y; Motoyama S; Minamiya Y
Pathobiology; 2020; 87(1):45-50. PubMed ID: 32023616
[TBL] [Abstract][Full Text] [Related]
37. Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.
Mendoza DP; Stowell J; Muzikansky A; Shepard JO; Shaw AT; Digumarthy SR
Clin Lung Cancer; 2019 Sep; 20(5):339-349. PubMed ID: 31164317
[TBL] [Abstract][Full Text] [Related]
38. Low ALK FISH positive metastatic non-small cell lung cancer (NSCLC) patients have shorter progression-free survival after treatment with ALK inhibitors.
Toruner GA; Tang Z; Tang G; Medeiros LJ; Hu S
Cancer Genet; 2020 Feb; 241():57-60. PubMed ID: 31870845
[TBL] [Abstract][Full Text] [Related]
39. [Identification of an optimal algorithm for effective diagnostics of non-small cell lung cancer with ALK gene rearrangement - implementation of the method and practical experiences with routine diagnostics].
Rozkoš T; Ryška A; Nová M; Hornychová H; Krbal L; Matěj R; Laco J
Cesk Patol; 2017; 53(2):89-96. PubMed ID: 28597670
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer.
Ginestet F; Lambros L; Le Flahec G; Marcorelles P; Uguen A
Clin Lung Cancer; 2018 Sep; 19(5):e647-e653. PubMed ID: 29801706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
